Effect of COPD on Inflammation, Lymphoid Functions and Progression-Free Survival during First-Line Chemotherapy in Advanced Non-small Cell Lung Cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1532-2807
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Effect of COPD on Inflammation, Lymphoid Functions and Progression-Free Survival during First-Line Chemotherapy in Advanced Non-small Cell Lung Cancer ; day:14 ; month:5 ; year:2019 ; pages:1-12
Pathology & oncology research ; (14.5.2019), 1-12
- Creator
-
Szentkereszty, Márton
Komlósi, Zsolt István
Szűcs, Gergő
Barna, Gábor
Tamási, Lilla
Losonczy, György
Gálffy, Gabriella
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12253-019-00661-w
- URN
-
urn:nbn:de:101:1-2019062501010953415645
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Szentkereszty, Márton
- Komlósi, Zsolt István
- Szűcs, Gergő
- Barna, Gábor
- Tamási, Lilla
- Losonczy, György
- Gálffy, Gabriella
- SpringerLink (Online service)
Other Objects (12)
Sex differences in lymphoid follicles in COPD airways
Radiomics combined with clinical characteristics predicted the progression-free survival time in first-line targeted therapy for advanced non-small cell lung cancer with EGFR mutation
Factors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer
IL-18 associated with lung lymphoid aggregates drives IFNγ production in severe COPD
Association between intermediate end points, progression-free survival, and overall survival in first-line advanced or recurrent endometrial cancer
Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma
First-line management of metastatic non-small cell lung cancer: An Indian perspective
Progression-free sets and rank of matrices
Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy
Time-dependent efficacy analysis of first-line immunotherapies for advanced non–small cell lung cancer
First-line treatment of EGFR-mutated nonsmall cell lung cancer : critical review on study methodology
Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma—an exploration of surrogate endpoint
Sex differences in lymphoid follicles in COPD airways
Radiomics combined with clinical characteristics predicted the progression-free survival time in first-line targeted therapy for advanced non-small cell lung cancer with EGFR mutation
Factors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer
IL-18 associated with lung lymphoid aggregates drives IFNγ production in severe COPD
Association between intermediate end points, progression-free survival, and overall survival in first-line advanced or recurrent endometrial cancer
Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma
First-line management of metastatic non-small cell lung cancer: An Indian perspective
Progression-free sets and rank of matrices
Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy
Time-dependent efficacy analysis of first-line immunotherapies for advanced non–small cell lung cancer
First-line treatment of EGFR-mutated nonsmall cell lung cancer : critical review on study methodology
Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma—an exploration of surrogate endpoint
Sex differences in lymphoid follicles in COPD airways
Radiomics combined with clinical characteristics predicted the progression-free survival time in first-line targeted therapy for advanced non-small cell lung cancer with EGFR mutation
Factors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer
IL-18 associated with lung lymphoid aggregates drives IFNγ production in severe COPD
Association between intermediate end points, progression-free survival, and overall survival in first-line advanced or recurrent endometrial cancer
Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma
First-line management of metastatic non-small cell lung cancer: An Indian perspective
Progression-free sets and rank of matrices
Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy
Time-dependent efficacy analysis of first-line immunotherapies for advanced non–small cell lung cancer
First-line treatment of EGFR-mutated nonsmall cell lung cancer : critical review on study methodology